Antifungal Activity of Propolis Against Yeasts Isolated From Blood Culture: In Vitro Evaluation

Journal of Clinical Laboratory Analysis
Fatma Mutlu SariguzelGonca Demir

Abstract

Due to the failure of available antifungal agents in the treatment of candidemia and the toxic activities of these drugs, a lot of researches are being conducted to develop new nontoxic and effective antifungal agents for optimal control of fungal pathogens. The aim of this study is to evaluate the in vitro antifungal activity of propolis against yeasts isolated from the blood cultures of intensive care unit patients. Seventy-six strains were included in this study. The in vitro antifungal activity of propolis, fluconazole (FLU), and itraconazole (ITR) was investigated by the microdilution broth methods (CLSI guidelines M27-A3 for yeast). The propolis sample was collected from Kayseri, Turkey. Of the 76 isolates, 33 were identified as Candida albicans while 37 were C. parapsilosis, three were C. tropicalis, and three were identified as C. glabrata. The geometric mean range for MIC (μg/ml) with regard to all isolates was 0.077 to 3 μg/ml for FLU and ITR, and 0.375 to 0.70 μg/ml for propolis. It was shown that propolis had significant antifungal activity against all Candida strains and the MIC range of propolis was determined as 0185 to 3 μg/ml. This study demonstrated that propolis had significant antifungal activity against yea...Continue Reading

References

Mar 1, 1992·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·G P Bodey
Jan 1, 1995·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J R Wingard
Jun 1, 1997·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D Abi-SaidS Vartivarian
Jun 20, 1998·Clinical Microbiology Reviews·T C WhiteR A Bowden
Aug 3, 2004·Die Nahrung·Musa OzcanRamazan Yetişir
Apr 16, 2005·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·M PopovaV Bankova
Dec 3, 2005·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Y OzkulE Eroğlu
Jan 16, 2007·Clinical Microbiology Reviews·M A Pfaller, D J Diekema
Dec 7, 2010·Journal of Medicinal Food·Ayşe Nedret KoçBariş Derya Ercal

❮ Previous
Next ❯

Citations

Feb 8, 2019·Current Pharmaceutical Biotechnology·Rawan ZeitounYolla El-Makhour
Jul 14, 2017·Frontiers in Pharmacology·Laura CornaraBruno Burlando
Jun 3, 2021·Biology·Nelly Rivera-YañezOscar Nieto-Yañez
Jul 3, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Magdalena RatajczakJan Matysiak

❮ Previous
Next ❯

Related Concepts

Related Feeds

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.